Cargando…

Prognostic factors and the necessity of chemotherapy for stage II gastric cancer: a model based on multicenter retrospective study

BACKGROUND: This study aimed to construct a prognostic model for prognosis prediction and assess the response to adjuvant chemotherapy (ACT) of stage II gastric cancer (GC) patients on high and low survival risk stratifications. METHODS: We retrospectively reviewed 547 stage II gastric cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jiaming, Zhang, Feiyang, Lu, Jun, Deng, Zijian, Li, Xianzhe, Chen, Xijie, Huang, Changming, Chen, Yingbo, Lian, Lei, Peng, Junsheng, Chen, Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167061/ https://www.ncbi.nlm.nih.gov/pubmed/37154867 http://dx.doi.org/10.1007/s12672-023-00663-w

Ejemplares similares

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Implication of perineural invasion in patients with stage II gastric cancer
por: Luo, Dandong, et al.
Publicado: (2023)

Analysis and external validation of a nomogram to predict peritoneal dissemination in gastric cancer
por: Chen, Xijie, et al.
Publicado: (2020)

A nomogram to predict prognosis for gastric cancer with peritoneal dissemination
por: Chen, Shi, et al.
Publicado: (2018)

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021)

Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination
por: Nie, Runcong, et al.
Publicado: (2016)

A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma
por: Yang, Kaixuan, et al.
Publicado: (2021)

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2018)

Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study
por: Gao, Xianchun, et al.
Publicado: (2023)

Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer
por: Zhang, Fengxiang, et al.
Publicado: (2023)

Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
por: Chen, Shi, et al.
Publicado: (2017)

Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer
por: Zhang, Fengxiang, et al.
Publicado: (2022)

Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection
por: Chen, Huaxian, et al.
Publicado: (2023)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study
por: Zhu, Linghua, et al.
Publicado: (2020)

Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

Prognostic Autophagy-Related Genes of Gastric Cancer Patients on Chemotherapy
por: Liu, Xiaolong, et al.
Publicado: (2021)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2019)

Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery
por: Chen, Yi-Fu, et al.
Publicado: (2022)

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol
por: Namikawa, Tsutomu, et al.
Publicado: (2018)

The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China
por: Yang, Yongqiang, et al.
Publicado: (2019)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
por: Chang, Hui, et al.
Publicado: (2019)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
por: Takenaka, T., et al.
Publicado: (1997)

Chemotherapy use and survival in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study
por: Shih, Yu-Hsuan, et al.
Publicado: (2023)

Necessity of Harvesting At Least 25 Lymph Nodes in Patients With Stage N2–N3 Resectable Gastric Cancer: A 10-year, Single-institution Cohort Study
por: Chen, Hai-Ning, et al.
Publicado: (2015)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
por: Peng, Hao, et al.
Publicado: (2021)

Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
por: Chen, Yonghe, et al.
Publicado: (2021)

Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy
por: Ruan, Hanguang, et al.
Publicado: (2017)

Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II–III
por: Li, Jingjing, et al.
Publicado: (2020)

Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?
por: Zhang, Chun-Dong, et al.
Publicado: (2016)

Naming and necessity /
por: Kripke, Saul A., 1940-
Publicado: (1980)

The nature of necessity
por: Plantinga, Alvin
Publicado: (1974)

Chance and necessity
por: Monod, Jacques
Publicado: (1974)

Design by necessity
por: Petsko, Gregory A
Publicado: (2001)

Necessity of Telemedicine
por: Mirhashemi, Sedigheh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mcihron7b3civlfo65a15bui40